# The Research of Standard Diagnosis and Treatment for Severe HSP in Children

> **NCT02540720** · PHASE2 · UNKNOWN · sponsor: **Nanjing Children's Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Henoch-Schoenlein Purpura

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Gamma globulin
- **PROCEDURE:** Hemoperfusion

## Key facts

- **NCT ID:** NCT02540720
- **Lead sponsor:** Nanjing Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2020-07
- **Final completion:** 2020-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02540720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02540720, "The Research of Standard Diagnosis and Treatment for Severe HSP in Children". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02540720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*